This Medudy course is a video tutorial for physicians on the topic of "TransCon PT in hypoparathyroidism". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you.
Conventional treatment of hypoparathyroidism focuses on relieving hypocalcemia symptoms but does not address the underlying PTH deficiency. TransCon PTH is a long-acting PTH prodrug that ensures stable physiological PTH levels over 24 hours. In today's ongoing extension study, the long-term safety and efficacy over 52 weeks are being investigated.
Note: All "speakers" appearing in the Medudy videos are AI-based avatars used to improve the didactics of the videos. The people on whom the avatars are based have explicitly consented to their use. All content is based on high-quality scientific sources and is created and reviewed by the Medudy medical team.
At the end of this training you will know:
- the clinical background and relevance of the research question under investigation
- Study design and methodology of the publication to answer the research question
- the results and key takeaways of the publication
- the conclusion of the publication and possible limitations
